Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNF14 pseudogene 2 (RNF14P2) is a **pseudogene** in humans, indicated by its nomenclature and current database annotations[6][9]. As a pseudogene, it is a non-functional segment of DNA that arises from a duplication or mutation of the parental RNF14 gene, which itself encodes a ring finger protein involved in ubiquitin ligase activity and acts as a transcriptional coactivator and translation quality control factor[1][3][4]. However, RNF14P2 lacks the capacity to produce a functional protein and does not have a demonstrated role as a drug target, biomarker, or disease factor. Some pseudogenes can generate non-coding RNA transcripts with possible regulatory functions, but there is no current evidence for such a role for RNF14P2[2][6][9].\n\n**Key context:**\n- The canonical RNF14 gene is a well-characterized E3 ubiquitin ligase and coactivator with established biological functions and clinical associations[1][3][4].\n- RNF14P2 is strictly annotated as a pseudogene in multiple authoritative genome resources and has no known functional protein product or validated biological role[5][6][9].\n- The query is for a pseudogene, not a therapeutic target, and thus does not map to standard target knowledge frameworks.\n\n**Cautions:**\n- If the intention was to gather information for drug targeting or functional annotation, RNF14P2 is not an appropriate entry as it is non-functional and not druggable.\n- There are no disease associations, mechanism of action, interacting drugs, biomarker utility, or safety considerations for RNF14P2.\n\n**Summary:**\n**RNF14 pseudogene 2** (RNF14P2) is a non-coding pseudogene with no established biological function, therapeutic role, or involvement in disease. It should not be considered a drug target or active molecular entity[6][9].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNF14 pseudogene 2 (RNF14P2).